AR073497A1 - Compuestos de pirazolilo policiclicos de n-sulfonamido - Google Patents

Compuestos de pirazolilo policiclicos de n-sulfonamido

Info

Publication number
AR073497A1
AR073497A1 ARP090103413A ARP090103413A AR073497A1 AR 073497 A1 AR073497 A1 AR 073497A1 AR P090103413 A ARP090103413 A AR P090103413A AR P090103413 A ARP090103413 A AR P090103413A AR 073497 A1 AR073497 A1 AR 073497A1
Authority
AR
Argentina
Prior art keywords
alkyl
alkoxy
groups
halogen
aryl
Prior art date
Application number
ARP090103413A
Other languages
English (en)
Spanish (es)
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Publication of AR073497A1 publication Critical patent/AR073497A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP090103413A 2008-09-05 2009-09-04 Compuestos de pirazolilo policiclicos de n-sulfonamido AR073497A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9479908P 2008-09-05 2008-09-05
US9924108P 2008-09-23 2008-09-23
US17327809P 2009-04-28 2009-04-28
US22653209P 2009-07-17 2009-07-17

Publications (1)

Publication Number Publication Date
AR073497A1 true AR073497A1 (es) 2010-11-10

Family

ID=41258775

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103413A AR073497A1 (es) 2008-09-05 2009-09-04 Compuestos de pirazolilo policiclicos de n-sulfonamido

Country Status (20)

Country Link
US (1) US8283358B2 (cg-RX-API-DMAC7.html)
EP (1) EP2346863A2 (cg-RX-API-DMAC7.html)
JP (1) JP2012502051A (cg-RX-API-DMAC7.html)
KR (1) KR20110055715A (cg-RX-API-DMAC7.html)
CN (1) CN102203089A (cg-RX-API-DMAC7.html)
AR (1) AR073497A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009289579A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0918213A2 (cg-RX-API-DMAC7.html)
CA (1) CA2736767A1 (cg-RX-API-DMAC7.html)
CL (1) CL2011000405A1 (cg-RX-API-DMAC7.html)
CO (1) CO6362008A2 (cg-RX-API-DMAC7.html)
EA (1) EA201170421A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP11010947A (cg-RX-API-DMAC7.html)
IL (1) IL211263A0 (cg-RX-API-DMAC7.html)
MA (1) MA32688B1 (cg-RX-API-DMAC7.html)
MX (1) MX2011002047A (cg-RX-API-DMAC7.html)
PE (1) PE20110418A1 (cg-RX-API-DMAC7.html)
TW (1) TW201014856A (cg-RX-API-DMAC7.html)
WO (1) WO2010028213A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201101994B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009289649B2 (en) 2008-09-03 2016-05-05 Biomarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
US8283358B2 (en) 2008-09-05 2012-10-09 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2012118782A1 (en) 2011-02-28 2012-09-07 Repligen Corporation Histone deacetylase inhibitors
RU2665554C2 (ru) 2013-03-15 2018-08-31 Байомарин Фармасьютикал Инк. Ингибиторы hdac
EP4084797A4 (en) * 2020-01-03 2024-02-21 Blue Oak Pharmaceuticals, Inc. COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISEASES
CN111909217B (zh) * 2020-08-20 2023-05-02 昆明贵金属研究所 一种双(二叔丁基-4-二甲氨基苯基膦)四溴双钯(ⅱ)化合物及其制备方法和用途
CN115448892B (zh) * 2022-09-19 2023-07-07 郑州铁路职业技术学院 一种苯并噻二唑杂环化合物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727989D0 (en) * 1987-11-30 1988-01-06 Merck Sharp & Dohme Therapeutic agents
EP0330788A1 (en) 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
WO2005113542A2 (en) 2004-05-20 2005-12-01 Elan Pharmaceuticals, Inc. N-cyclic sulfonamido inhibitors of gamma secretase
JP2009504773A (ja) * 2005-08-19 2009-02-05 エラン ファーマシューティカルズ,インコーポレイテッド ガンマセクレターゼの架橋n−二環式スルホンアミド阻害剤
TW200813054A (en) 2006-06-02 2008-03-16 Elan Pharm Inc Fused, tricyclic sulfonamide inhibitors of gamma secretase
CN101128035B (zh) 2006-08-18 2011-08-24 中兴通讯股份有限公司 时分码分多址系统中信道间的定时方法
MX2009012525A (es) * 2007-05-25 2009-12-09 Elan Pharm Inc Pirazol-pirrolidinas como inhibidores de gamma secretasa.
US8283358B2 (en) 2008-09-05 2012-10-09 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds

Also Published As

Publication number Publication date
EP2346863A2 (en) 2011-07-27
IL211263A0 (en) 2011-04-28
US20100081680A1 (en) 2010-04-01
KR20110055715A (ko) 2011-05-25
EA201170421A1 (ru) 2012-01-30
ECSP11010947A (es) 2011-07-29
BRPI0918213A2 (pt) 2015-12-08
CO6362008A2 (es) 2012-01-20
MX2011002047A (es) 2011-06-17
AU2009289579A1 (en) 2010-03-11
TW201014856A (en) 2010-04-16
WO2010028213A2 (en) 2010-03-11
US8283358B2 (en) 2012-10-09
PE20110418A1 (es) 2011-06-22
ZA201101994B (en) 2011-11-30
CN102203089A (zh) 2011-09-28
CL2011000405A1 (es) 2011-07-01
MA32688B1 (fr) 2011-10-02
WO2010028213A3 (en) 2010-06-03
CA2736767A1 (en) 2010-03-11
JP2012502051A (ja) 2012-01-26

Similar Documents

Publication Publication Date Title
RU2017123114A (ru) 3-оксо-3-(ариламино)пропионаты, способ их получения и их применение в получении пирролидинонов
AR065081A1 (es) Compuestos de quinazolinona y pirimidona fusionados y composicion farmaceutica
ES2855732T3 (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad de NLRP
AR065194A1 (es) Compuestos de piridopirimidinona de utilidad en el tratamiento de enfermedades o condiciones patologicas mediadas por los canales de sodio
AR065811A1 (es) Derivados de 2-amino-4h-imidazol-4-ona,composiciones farmaceuticas que los contienen y usos para el tratamiento de la enfermedad de alzheimer y otros trastornos neurodegenerativos.
AR063213A1 (es) Amidas azociclicas fungicidas, composiciones fungicidas que las comprenden y su empleo en un metodo para controlar enfermedades en las plantas causadas por patogenos fungicos de la clase de los oomycetes.
AR045219A1 (es) Aminas ciclicas inhibidoras de base - 1 que poseen un sustiuyente heterociclico
AR069804A1 (es) Agonistas del receptor glucocorticoide c20- c21 sustituido
AR066459A1 (es) Derivados de oxadiazol como moduladores de gamma-secretasa. composiciones farmaceuticas
RU2012119488A (ru) Конденсированные азиновые производные для лечения заболеваний, связанных с ацетилхолиновым рецептором
CO6150164A2 (es) Derivados de 2-metilmorfolina pirido-,pirazo-ypirimido-pirimidina como inhibidores de mtor
AR069185A1 (es) Compuestos heterociclicos moduladores de gamma secretasa, composiciones farmaceuticas que los contienen y usos de los mismos para tratar trastornos del snc, tales como enfermedad de alzheimer y otras relacionadas con la deposicion de proteinas amiloides.
AR104214A1 (es) Amidas cíclicas sustituidas como herbicidas
AR048537A1 (es) Derivados de nucleosidos para tratar infecciones por virus de hepatitis c.
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR057626A1 (es) Derivados de pirido pirazo y pirimido- pirimidina y su uso como inhibidores de mtor
ES470209A1 (es) Un procedimiento para la preparacion de nuevos derivados de mevalonolactona
AR056317A1 (es) Compuestos de oxindol y composicion farmaceutica
AR056043A1 (es) Agonistas de receptores adrenergicos alfa2c funcionalmente selectivos
BR112012003955A2 (pt) compostos heterocíclicos tricíclicos como inibidores da fosfoinositídeos 3-quinase
PE20090893A1 (es) Derivados de pirazol como antagonistas del receptor ccr2 y/o ccr5
AR059176A1 (es) Compuesto de indol, composicion farmaceutica que lo comprende, metodo para prepararlo y su uso para preparar dicha composicion y para la manufactura de un medicamento para el tratamiento o prevencion de leiomiomas y endometriosis.
RU2014120210A (ru) (гетеро)арилциклопропиламины в качестве ингибиторов lsd1
AR105544A1 (es) Compuestos de n-carboxamida cíclica útiles como herbicidas
JP2013528602A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal